bromocriptine has been researched along with Cognition Disorders in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, RH; Bondi, CO; Kline, AE; Olugbade, YT; Phelps, TI | 1 |
| Elovic, EP; Napolitano, E; Qureshi, AI | 1 |
| Coslett, HB; Grieb-Neff, P; Hart, T; Polansky, M; Vaccaro, M; Whyte, J | 1 |
| Angrist, B; Lieberman, A; Serby, M | 1 |
| al-Adawi, S; Greenwood, RJ; Morgan, J; Powell, JH | 1 |
| Graham, JM; Grünewald, RA; Sagar, HJ | 1 |
| Fujimori, M; Hattori, N; Imamura, T; Ishii, K; Takanashi, M; Yamadori, A; Yamashita, H | 1 |
| Cooper, JA; Doherty, SM; Jordan, N; Sagar, HJ; Sullivan, EV; Tidswell, P | 1 |
| Cramer, H; Kuntzmann, F; Masson, H; Popescu, I; Strubel, D | 1 |
| Berthier, ML; Leiguarda, R; Starkstein, SE | 1 |
| Montastruc, JL; Rascol, A; Schmitt, L; Simonetta, M | 1 |
2 review(s) available for bromocriptine and Cognition Disorders
| Article | Year |
|---|---|
Pharmacological stimulant treatment of neurocognitive and functional deficits after traumatic and non-traumatic brain injury.
Topics: Amantadine; Animals; Brain Injuries; Bromocriptine; Cognition Disorders; Dextroamphetamine; Humans; Levodopa; Methylphenidate | 2005 |
Psychic akinesia following bilateral pallidal lesions.
Topics: Adult; Bromocriptine; Carbon Monoxide Poisoning; Cognition Disorders; Globus Pallidus; Humans; Male; Neuropsychological Tests; Tomography, X-Ray Computed | 1989 |
4 trial(s) available for bromocriptine and Cognition Disorders
| Article | Year |
|---|---|
The effects of bromocriptine on attention deficits after traumatic brain injury: a placebo-controlled pilot study.
Topics: Adolescent; Adult; Attention; Attention Deficit Disorder with Hyperactivity; Brain Injuries; Bromocriptine; Cognition Disorders; Cross-Over Studies; Disability Evaluation; Dopamine Agonists; Female; Humans; Male; Middle Aged; Psychological Tests; Psychometrics; Reaction Time; Statistics, Nonparametric; Surveys and Questionnaires | 2008 |
Motivational deficits after brain injury: effects of bromocriptine in 11 patients.
Topics: Adult; Brain Injuries; Bromocriptine; Cognition Disorders; Dopamine Agonists; Female; Humans; Male; Middle Aged; Motivation; Subarachnoid Hemorrhage; Treatment Outcome | 1996 |
Bromocriptine treatment for perseveration in demented patients.
Topics: Aged; Aged, 80 and over; Attention; Bromocriptine; Cognition Disorders; Dementia; Dopamine Agonists; Female; Humans; Inhibition, Psychological; Male; Middle Aged; Neuropsychological Tests; Treatment Outcome; Volition | 1998 |
Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients.
Topics: Adult; Aged; Bromocriptine; Cognition Disorders; Female; Follow-Up Studies; Frontal Lobe; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Motor Activity; Movement; Parasympatholytics; Parkinson Disease; Psychomotor Performance; Visual Perception | 1992 |
5 other study(ies) available for bromocriptine and Cognition Disorders
| Article | Year |
|---|---|
Divergent long-term consequences of chronic treatment with haloperidol, risperidone, and bromocriptine on traumatic brain injury-induced cognitive deficits.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Brain Injuries; Bromocriptine; Cognition Disorders; Dopamine Agonists; Haloperidol; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Recovery of Function; Risperidone; Time Factors | 2015 |
Psychiatric effects of bromocriptine and lergotrile in Parkinsonian patients.
Topics: Aged; Bromocriptine; Cognition Disorders; Confusion; Dose-Response Relationship, Drug; Electroencephalography; Ergolines; Female; Humans; Male; Mental Disorders; Middle Aged; Parkinson Disease; Personality Disorders; Psychoses, Substance-Induced; Schizophrenia | 1980 |
Hallucinosis in idiopathic Parkinson's disease.
Topics: Aged; Bromocriptine; Cognition Disorders; Depressive Disorder; Dopamine Agonists; Female; Hallucinations; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Psychomotor Disorders; Retrospective Studies; Severity of Illness Index; Time Factors | 1997 |
Somatostatin-like immunoreactivity in the cerebrospinal fluid of aged patients with Parkinson's disease. The effect of dopatherapy.
Topics: Aged; Aged, 80 and over; Benserazide; Bromocriptine; Cognition Disorders; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Parkinson Disease; Severity of Illness Index; Somatostatin | 1990 |
[Neuropsychic side effects of bromocriptine in Parkinson's disease].
Topics: Aged; Bromocriptine; Cognition Disorders; Delusions; Female; Hallucinations; Humans; Male; Mental Disorders; Middle Aged; Parkinson Disease | 1987 |